Biggest quarter ahead from the company and peers after the pre clinical success and 8 years of development to this point are trading at 70-100 million market caps. 10 million market cap with 10 million in funding is a joke. The below tells you where this is going. Should be trading at a 60-70 cent share price leading into phase 2 but it’s coming
Biggest quarter ahead from the company and peers after the pre...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.023(26.4%) |
Mkt cap ! $17.85M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $249.0K | 2.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19019 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 197198 | 6 |
View Market Depth
| Last trade - 12.56pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |